Document:

<PAGE>

                                                                    EXHIBIT 10.2

                                  Restricted Stock Award Number: _______________
                                            Purchase ID Number: ________________

                                 ENDOLOGIX, INC.

                        RESTRICTED STOCK AWARD AGREEMENT
                                      UNDER
                            2006 STOCK INCENTIVE PLAN

     THIS RESTRICTED STOCK AWARD AGREEMENT (the "Agreement") is entered into as
of __________, 200_ by and between __________ (hereinafter referred to as
"Purchaser") and Endologix, Inc., a Delaware corporation (hereinafter referred
to as the "Company"), pursuant to the Company's 2006 Stock Incentive Plan (the
"Plan"). Any capitalized term not defined herein shall have the same meaning
ascribed to it in the Plan.

                                    RECITALS:

     A. Purchaser is an employee or director of the Company, and in connection
therewith has rendered services for and on behalf of the Company or any
Affiliated Company.

     B. The Company desires to issue shares of the Company's Common Stock to
Purchaser for the consideration set forth herein to provide an incentive for
Purchaser to remain in the service of the Company and to exert added effort
towards its growth and success.

     NOW, THEREFORE, in consideration of the mutual covenants hereinafter set
forth, and for other good and valuable consideration, the parties agree as
follows:

          1. ISSUANCE OF SHARES. The Company hereby offers to issue to Purchaser
an aggregate of __________ (__________) shares of Common Stock of the Company
(the "Shares") on the terms and conditions herein set forth. Unless this offer
is earlier revoked in writing by the Company, Purchaser shall have ten (10) days
from the date of the delivery of this Agreement to Purchaser to accept the offer
of the Company by executing and delivering to the Company two (2) copies of this
Agreement, without condition or reservation of any kind whatsoever, together
with the consideration to be delivered by Purchaser pursuant to Section 2 below,
if applicable.

          2. CONSIDERATION. The purchase price for the Shares shall be
__________ ($_____) per share, or a total of _____________ ($__________).

          3. VESTING OF SHARES.

               (A) Subject to Section 3(b) below, the Shares acquired hereunder
shall vest and become "Vested Shares" as follows:

        [INSERT VESTING SCHEDULE, EITHER TIME-BASED OR PERFORMANCE-BASED]

No additional shares shall vest after the date of termination of Purchaser's
Continuous Service.

     As used herein, the term "Continuous Service" means (i) employment by
either the Company or any parent or subsidiary corporation of the Company, or by
any successor entity following a Change in Control, which is uninterrupted
except for paid vacations or sick days in accordance with

<PAGE>

Company policy, as applicable, or (ii) service as a member of the Board of
Directors of the Company until Purchaser resigns, is removed from office, or
Purchaser's term of office expires and he or she is not reelected. The
Purchaser's Continuous Service shall not terminate merely because of a change in
the capacity in which the Purchaser renders service to the Company or a
corporation or subsidiary corporation described in clause (i) above. For
example, a change in the Purchaser's status from an employee to a Non-Employee
Director will not constitute an interruption of the Purchaser's Continuous
Service, provided there is no interruption in the Purchaser's performance of
such services.

               (B) Notwithstanding Section 3(a) above, if Purchaser holds Shares
at the time a Change in Control occurs, the acquiring or successor entity (or
parent thereof) does not agree to provide for the continuance or assumption of
this Agreement or the substitution for this Agreement of a new agreement of
comparable value covering shares of a successor corporation (with appropriate
adjustments as to the number and kind of shares and the purchase price), then
all "Repurchase Rights" (as defined in Section 4 below) shall automatically
terminate immediately prior to the consummation of such Change in Control and
the Shares subject to those terminated Repurchase Rights shall immediately vest
in full. Notwithstanding the foregoing sentence, if pursuant to a Change in
Control the acquiring or successor entity (or parent thereof) provides for the
continuance or assumption of this Agreement or the substitution for this
Agreement of a new agreement of comparable value covering shares of a successor
corporation (with appropriate adjustments as to the number and kind of shares
and the purchase price), then the Repurchase Rights shall not terminate and
vesting of the Shares shall not accelerate in connection with such Change in
Control to the extent this Agreement is continued, assumed or substituted for;
provided, however, if Purchaser's Continuous Service is terminated without Cause
or pursuant to an Involuntary Termination (as defined below) within twelve (12)
months following such Change in Control, all Repurchase Rights shall terminate
and vesting of the Shares or any substituted shares shall accelerate in full
automatically effective upon such termination. For purposes of this Section 3,
the following terms shall have the meanings set forth below:

                    (I) "Cause" shall mean (A) the commission of any act of
fraud, embezzlement or dishonesty by Purchaser which materially and adversely
affects the business of the Company, the acquiring or successor entity (or
parent or any subsidiary thereof), (B) any unauthorized use or disclosure by
Purchaser of confidential information or trade secrets of the Company, the
acquiring or successor entity (or parent or any subsidiary thereof), (C) the
continued refusal or omission by the Purchaser to perform any material duties
required of him if such duties are consistent with duties customary for the
position held with the Company, the acquiring or successor entity (or parent or
any subsidiary thereof), (D) any material act or omission by the Purchaser
involving malfeasance or gross negligence in the performance of Purchaser's
duties to, or material deviation from any of the policies or directives of, the
Company or the acquiring or successor entity (or parent or any subsidiary
thereof), (E) conduct on the part of Purchaser which constitutes the breach of
any statutory or common law duty of loyalty to the Company, the acquiring or
successor entity (or parent or any subsidiary thereof), or (F) any illegal act
by Purchaser which materially and adversely affects the business of the Company,
the acquiring or successor entity (or parent or any subsidiary thereof), or any
felony committed by Purchaser, as evidenced by conviction thereof. The
provisions of this Section shall not limit the grounds for the dismissal or
discharge of Purchaser or any other individual in the service of the Company,
the acquiring or successor entity (or parent or any subsidiary thereof).

                                        2

<PAGE>

                    (II) "Involuntary Termination" shall mean the termination of
Purchaser's Continuous Service by reason of:

                         (A) Purchaser's involuntary dismissal or discharge by
the Company, or by the acquiring or successor entity (or parent or any
subsidiary thereof employing the Purchaser) for reasons other than Cause (as
defined above), or

                         (B) Purchaser's voluntary resignation within thirty
(30) days following (x) a change in Purchaser's position with the Company, the
acquiring or successor entity (or parent or any subsidiary thereof) which
materially reduces Purchaser's duties and responsibilities or the level of
management to which Purchaser reports, (y) a reduction in Purchaser's level of
compensation (including base salary, fringe benefits and target bonus under any
performance based bonus or incentive programs) by more than ten percent (10%),
or (z) a relocation of Purchaser's principal place of employment by more than
thirty (30) miles, provided and only if such change, reduction or relocation is
effected without Purchaser's written consent.

     In the event that the Purchaser is a party to an employment agreement or
other similar agreement with the Company or any Affiliated Company that defines
a termination on account of "Cause" or "Involuntary Termination" (or terms
having similar meanings), such definitions shall apply as the definitions of a
termination on account of "Cause" or pursuant to an "Involuntary Termination"
for purposes hereof, but only to the extent that such definition provides the
Purchaser with greater rights.

          4. RECONVEYANCE UPON TERMINATION OF SERVICE.

               (A) REPURCHASE RIGHT. The Company shall have the right (but not
the obligation) to repurchase all or any part of the Unvested Shares (the
"Repurchase Right") in the event that the Purchaser's Continuous Service
terminates for any reason. Upon exercise of the Repurchase Right, the Purchaser
shall be obligated to sell his or her Unvested Shares to the Company, as
provided in this Section 4. If the Purchase Price paid for the Shares is zero,
then upon termination of Continuous Service Purchaser shall be obligated to
transfer his or her Unvested Shares to the Company without consideration.

               (B) CONSIDERATION FOR REPURCHASE RIGHT. The repurchase price of
the Unvested Shares (the "Repurchase Price") shall be equal to the Purchase
Price, if any, of such Unvested Shares.

               (C) PROCEDURE FOR EXERCISE OF RECONVEYANCE OPTION. For sixty (60)
days after the Termination Date or other event described in this Section 4, the
Company may exercise the Repurchase Right by giving Purchaser and/or any other
person obligated to sell written notice of the number of Unvested Shares which
the Company desires to purchase. The Repurchase Price for the Unvested Shares
shall be payable, at the option of the Company, by check or by cancellation of
all or a portion of any outstanding indebtedness of Purchaser to the Company, or
by any combination thereof.

               (D) NOTIFICATION AND SETTLEMENT. In the event that the Company
has elected to exercise the Repurchase Right as to part or all of the Unvested
Shares within the period described above, Purchaser or such other person shall
deliver to the Company certificate(s) representing the Unvested Shares to be
acquired by the Company within thirty (30) days following

                                        3

<PAGE>

the date of the notice from the Company. The Company shall deliver to Purchaser
against delivery of the Unvested Shares, checks of the Company payable to
Purchaser and/or any other person obligated to transfer the Unvested Shares in
the aggregate amount of the Repurchase Price, if any, to be paid as set forth in
paragraph 4(b) above.

               (E) DEPOSIT OF UNVESTED SHARES. Purchaser shall deposit with the
Company certificates representing the Unvested Shares, together with a duly
executed stock assignment separate from certificate in blank, which shall be
held by the Secretary of the Company. Purchaser shall be entitled to vote and to
receive dividends and distributions on all such deposited Unvested Shares.

               (F) TERMINATION. The provisions of this Section 4 shall
automatically terminate in accordance with Section 3(b) above.

               (G) ASSIGNMENT. The Company may assign its Repurchase Right under
this Section 4 without the consent of the Purchaser.

          5. RESTRICTIONS ON UNVESTED SHARES. Unvested Shares may not be sold,
transferred, pledged, or otherwise disposed of, except that such Unvested Shares
may be transferred to a trust established for the sole benefit of the Purchaser
and/or his or her spouse, children or grandchildren. Any Unvested Shares that
are transferred as provided herein remain subject to the terms and conditions of
this Agreement.

          6. ADJUSTMENTS UPON CHANGES IN CAPITAL STRUCTURE. In the event that
the outstanding Shares of Common Stock of the Company are hereafter increased or
decreased or changed into or exchanged for a different number or kind of shares
or other securities of the Company by reason of a recapitalization, stock split,
combination of shares, reclassification, stock dividend, or other change in the
capital structure of the Company, then Purchaser shall be entitled to new or
additional or different shares of stock or securities, in order to preserve, as
nearly as practical, but not to increase, the benefits of Purchaser under this
Agreement, in accordance with the provisions of Section 4.2 of the Plan. Such
new, additional or different shares shall be deemed "Shares" for purposes of
this Agreement and subject to all of the terms and conditions hereof.

          7. SHARES FREE AND CLEAR. All Shares purchased by the Company (or
otherwise returned to the Company) pursuant to this Agreement shall be delivered
by Purchaser free and clear of all claims, liens and encumbrances of every
nature (except the provisions of this Agreement and any conditions concerning
the Shares relating to compliance with applicable federal or state securities
laws), and the purchaser thereof shall acquire full and complete title and right
to all of such Shares, free and clear of any claims, liens and encumbrances of
every nature (again, except for the provisions of this Agreement and such
securities laws).

          8. LIMITATION OF COMPANY'S LIABILITY FOR NONISSUANCE; UNPERMITTED
TRANSFERS.

               (A) The Company agrees to use its reasonable best efforts to
obtain from any applicable regulatory agency such authority or approval as may
be required in order to issue and sell the Shares to Purchaser pursuant to this
Agreement. The inability of the Company to obtain, from any such regulatory
agency, authority or approval deemed by the Company's counsel to be necessary
for the lawful issuance and sale of the Shares hereunder and under the Plan
shall relieve

                                        4

<PAGE>

the Company of any liability in respect of the nonissuance or sale of such
Shares as to which such requisite authority or approval shall not have been
obtained.

               (B) The Company shall not be required to: (i) transfer on its
books any Shares of the Company which shall have been sold or transferred in
violation of any of the provisions set forth in this Agreement, or (ii) treat as
owner of such shares or to accord the right to vote as such owner or to pay
dividends to any transferee to whom such shares shall have been so transferred.

          9. NOTICES. All notices, requests, demands and other communications
required or permitted under this Agreement shall be in writing and shall be
deemed to have been duly given and effective (i) when delivered by hand, (ii)
when otherwise delivered against receipt therefor, or (iii) three (3) business
days after being mailed if sent by registered or certified mail, postage
prepaid, return receipt requested. Any notice shall be addressed to the parties
as follows or at such other address as a party may designate by notice given to
the other party in the manner set forth herein:

               (A) if to the Company:

               Endologix, Inc.
               11 Studebaker
               Irvine, CA 92618
               Attention: Chief Financial Officer

               (B) if to the Purchaser, at the address shown on the signature
page of this Agreement or at his most recent address as shown in the employment
or stock records of the Company.

     10. BINDING OBLIGATIONS. All covenants and agreements herein contained by
or on behalf of any of the parties hereto shall bind and inure to the benefit of
the parties hereto and their permitted successors and assigns.

     11. CAPTIONS AND SECTION HEADINGS. Captions and section headings used
herein are for convenience only, and are not part of this Agreement and shall
not be used in construing it.

     12. AMENDMENT. This Agreement may not be amended, waived, discharged, or
terminated other than by written agreement of the parties.

     13. ENTIRE AGREEMENT. This Agreement and the Plan constitute the entire
agreement between the parties with respect to the subject matter hereof and
supersede all prior or contemporaneous written or oral agreements and
understandings of the parties, either express or implied.

     14. ASSIGNMENT. Purchaser shall have no right, without the prior written
consent of the Company, to (i) sell, assign, mortgage, pledge or otherwise
transfer any interest or right created hereby, or (ii) delegate his or her
duties or obligations under this Agreement. This Agreement is made solely for
the benefit of the parties hereto, and no other person, partnership, association
or corporation shall acquire or have any right under or by virtue of this
Agreement.

                                        5

<PAGE>

     15. SEVERABILITY. Should any provision or portion of this Agreement be held
to be unenforceable or invalid for any reason, the remaining provisions and
portions of this Agreement shall be unaffected by such holding.

     16. COUNTERPARTS. This Agreement may be executed in one or more
counterparts, all of which taken together shall constitute one agreement and any
party hereto may execute this Agreement by signing any such counterpart. This
Agreement shall be binding upon Purchaser and the Company at such time as the
Agreement, in counterpart or otherwise, is executed by Purchaser and the
Company.

     17. APPLICABLE LAW. This Agreement shall be construed in accordance with
the laws of the State of California without reference to choice of law
principles, as to all matters, including, but not limited to, matters of
validity, construction, effect or performance.

     18. NO AGREEMENT TO EMPLOY. Nothing in this Agreement shall affect any
right with respect to continuance of employment by the Company or any of its
subsidiaries. The right of the Company or any of its subsidiaries to terminate
at will the Purchaser's employment at any time (whether by dismissal, discharge
or otherwise), with or without cause, is specifically reserved, subject to any
other written employment agreement to which the Company and Purchaser may be a
party.

     19. "MARKET STAND-OFF" AGREEMENT. Purchaser agrees that, if requested by
the Company or the managing underwriter of any proposed public offering of the
Company's securities (including any acquisition transaction where Company
securities will be used as all or part of the purchase price), Purchaser will
not sell or otherwise transfer or dispose of any Shares held by Purchaser
without the prior written consent of the Company or such underwriter, as the
case may be, during such period of time, not to exceed 180 days following the
effective date of the registration statement filed by the Company with respect
to such offering, as the Company or the underwriter may specify.

     20. TAX ELECTIONS. Purchaser understands that Purchaser (and not the
Company) shall be responsible for the Purchaser's own tax liability that may
arise as a result of the acquisition of the Shares. Purchaser acknowledges that
Purchaser has considered the advisability of all tax elections in connection
with the purchase of the Shares, including the making of an election under
Section 83(b) under the Internal Revenue Code of 1986, as amended ("Code");
Purchaser further acknowledges that the Company has no responsibility for the
making of such Section 83(b) election. In the event Purchaser determines to make
a Section 83(b) election, Purchaser agrees to timely provide a copy of the
election to the Company as required under the Code.

     21. ATTORNEYS' FEES. If any party shall bring an action in law or equity
against another to enforce or interpret any of the terms, covenants and
provisions of this Agreement, the prevailing party in such action shall be
entitled to recover reasonable attorneys' fees and costs.

                            [Signature Page Follows]

                                        6

<PAGE>

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the date first above written.

THE COMPANY:                            PURCHASER:

ENDOLOGIX, INC.

By:
    ---------------------------------   ----------------------------------------
Name:
      -------------------------------   ----------------------------------------
Title:                                                [Print Name]
       ------------------------------

                                        Address:

                                        ----------------------------------------

                                        ----------------------------------------

                                        7

<PAGE>

                       CONSENT AND RATIFICATION OF SPOUSE

     The undersigned, the spouse of _____________________, a party to the
attached Restricted Stock Award Agreement (the "Agreement"), dated as of
_______________, hereby consents to the execution of said Agreement by such
party; and ratifies, approves, confirms and adopts said Agreement, and agrees to
be bound by each and every term and condition thereof as if the undersigned had
been a signatory to said Agreement, with respect to the Shares (as defined in
the Agreement) made the subject of said Agreement in which the undersigned has
an interest, including any community property interest therein.

     I also acknowledge that I have been advised to obtain independent counsel
to represent my interests with respect to this Agreement but that I have
declined to do so and I hereby expressly waive my right to such independent
counsel.

Date:
      -------------------------------   ----------------------------------------
                                                       (Signature)

                                        ----------------------------------------
                                                      (Print Name)<PAGE>

                                                                 Exhibit 10.6.2

                      SECOND AMENDMENT TO SUPPLY AGREEMENT

        This Second Amendment to Supply Agreement (this "Second Amendment") is
entered into as of September 8, 2006 by and between Bard Peripheral Vascular,
Inc. (formerly known as IMPRA, Inc. and referred to herein as "BPV"), a
subsidiary of C. R. Bard, Inc., with offices at 1625 W. 3rd Street, Tempe, AZ
85281, and Endologix, Inc. a Delaware corporation, with offices at 11
Studebaker, Irvine, CA 92618 ("Endologix").

                                 R E C I T A L S

        WHEREAS, BPV and Endologix are parties to that certain Supply Agreement
dated February 12, 1999 (the "Supply Agreement"), as amended by the Amendment to
Supply Agreement dated January 17, 2002 (the "First Amendment"); and

        WHEREAS, BPV and Endologix desire to amend the Supply Agreement on the
terms and conditions set forth herein solely to modify the minimum purchase
requirements of Components for the remainder of 2006 and all of 2007.

                                    AGREEMENT

        In consideration of the foregoing premises, the mutual covenants and
agreements set forth herein, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto
hereby agree as follows:

        1.      Definitions. For purposes of this Second Amendment, unless
otherwise set forth herein, capitalized terms established in the Supply
Agreement and/or First Amendment shall be applied herein as defined therein.

        2.      Amendments.

               (a) The last sentence of Section (B) of Article IV of the Supply
Agreement (as set forth in the First Amendment) provided that the minimum
purchase requirements of Components by Endologix for each of the calendar years
2004 through 2007 would be a number of units of Components not less than 115% of
the previous year's minimum purchase requirements or actual purchases, whichever
is higher. The parties now desire to amend the Supply Agreement to provide for
minimum purchase requirements of Components by Endologix of a specified dollar
amount of Components (instead of units of Components) solely for the remainder
of 2006 and all of 2007. Therefore, the last sentence of Section (B) of Article
IV of the Supply Agreement (as set forth in the First Amendment) is hereby
deleted and is replaced with the following:

<PAGE>
                "The minimum purchases of Components by Endologix for calendar
                year 2006 shall be an aggregate of Two Million Five Hundred
                Thousand Dollars ($2,500,000.00) (i.e., an amount of units of
                Components whose aggregate purchase price equals or exceeds
                $2,500,000.00). The purchase of Components for the remainder of
                2006 shall be spread evenly among the remaining months of 2006
                (i.e., approximately $500,000.00 per month). The minimum
                purchases of Components by Endologix for the calendar year 2007
                shall be an aggregate of Two Million Eight Hundred Seventy-Five
                Thousand Dollars ($2,875,000.00) (i.e., an amount of units of
                Components whose aggregate purchase price equals or exceeds
                $2,875,000.00). The purchase of Components by Endologix in 2007
                shall be in a minimum quarterly amount of $600,000.00 until the
                aggregate minimum purchase of $2875,000.00 for 2007 is met.
                Purchase of Components by Endologix in 2006 and 2007 may be in
                any mix of product codes as set forth on Exhibit C attached to
                the First Amendment.

                (b) Endologix has provided to BPV purchase orders for Components
                for the remaining months of 2006 in connection with the
                execution of this Second Amendment in accordance with the terms
                of subsection 2(a) of this Second Amendment.

        3.      Miscellaneous

               (a) Entire Agreement. The Supply Agreement, as amended by the
First Amendment and this Second Amendment, constitutes the entire agreement
between the parties pertaining to the subject matter hereof and supersedes all
prior agreements, understandings, negotiations and discussions whether oral or
written of the parties.

               (b) Counterparts. This Second Amendment may be executed in one or
more counterparts, each of which shall be deemed an original instrument and all
of which together will constitute one and the same instrument. The exchange of
copies of this Second Amendment and of signature pages by facsimile transmission
shall constitute effective execution and delivery of this Second Amendment as to
the parties and may be used in lieu of the original for all purposes. Signatures
of parties transmitted by facsimile shall be deemed to be their original
signatures for any purpose whatsoever.

               (c) Effect of Second Amendment. Except as provided in this Second
Amendment, the Supply Agreement (as amended by the First Amendment) shall remain
unchanged and shall continue in full force and effect. In the event of a
conflict between this Second Amendment and the Supply Agreement (as amended by
the First Amendment), the terms of this Second Amendment shall govern and
control.

               (d) Performance. The price and minimum purchase requirements for
Components are set forth in Section 2.a. of the First Amendment and Section 2.a.
of this Second Amendment, respectively. Payment terms are 30 days from date of
shipment. During each specified period in 2006 and 2007, Endologix agrees that
it will purchase and take delivery of the applicable minimum purchase
requirements set forth in Section 2.a. of this Second Amendment. If, at the end
of any such period, Endologix has not purchased and taken delivery of such

                                       -2-
<PAGE>

minimum purchase requirements, other than due to BPV's inability to produce and
deliver Components ordered by Endologix, BPV may, at its option, invoice
Endologix for the difference between the minimum purchase requirements and the
value of the lesser quantity of the Components that Endologix actually purchased
and took delivery of during such period. Endologix will pay any such invoice
within thirty (30) days of its receipt. The failure of Endologix to pay any such
invoice will be deemed to be a material breach of the Supply Agreement.

        IN WITNESS WHEREOF, the parties have caused this Amendment to be duly
executed and delivered by their respective duly authorized officers as of the
date first written above.

Bard Peripheral Vascular, Inc.          Endologix, Inc.

By: /s/                                 By: /s/ Robert J. Krist
    ------------------------------          ---------------------------------
    President                               Chief Financial Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00112-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00112-of-00352.parquet"}]]